Stricter Norms for Assisted Reproductive Technology Clinics
By Kounteya Sinha,
The Times of India
| 04. 12. 2012
JAIPUR: All clinics in India, involved in treating infertility through procedures like artificial insemination with husband's semen (AIH) or in-vitro fertilization-embryo transfer (IVF), will now have to get registered in the country's first National Registry of Assisted Reproductive Technology (ART) clinics in India.
In order to regulate the ART trade in India, the Union health ministry and the Indian Council of Medical Research (ICMR) are setting up the Registry "with a view to providing appropriate help and assistance to all those who are engaged in taking care of infertility problems in the country."
All clinics practicing techniques such as Artificial Insemination with Donor Semen (AID), Gamete Intrafallopian Tube Transfer (GIFT), Tubal Embryo Transfer (TET), Intracytoplasmic Sperm Injection (ICSI), Testicular Sperm Aspiration (TESA), Testicular Sperm Extraction (TESE) or processing or storage of gametes (sperm and oocyte) and or embryos will have to be part of the Registry.
Each registrant will be given a unique registration number by the ICMR that could be used by the registrant for any legitimate purpose.
ICMR estimates that 15% of couples around the world are infertile...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...